Meeting
2015 ASCO Annual Meeting
Mild cognitive impairment (MCI) in chemotherapy-treated breast cancer survivors.
Authors
Abigail Gifford
Wake Forest University, School of Medicine, Winston-Salem, NC
Abigail Gifford , Julia Lawrence , Doug Case , Steve Rapp , Laura Baker , Suzanne Craft , David L. Groteluschen , Heidi Klepin , Glenn Lesser , Michelle Joy Naughton , Bonnie Sachs , Thomas A. Samuel , Kaycee Sink , Jeff Williamson , Edward G. Shaw
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Survivorship
Citation
J Clin Oncol 33, 2015 (suppl; abstr 9560)
DOI
10.1200/jco.2015.33.15_suppl.9560
Abstract #
9560
Poster Bd #
219
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Phase 3 randomized placebo-controlled trial of donepezil for cancer-related cognitive impairment among breast cancer survivors: Results on patient-reported cognitive function from the Wake Forest NCI Community Oncology Research Program (NCORP) Research Base REMEMBER trial (WF97116).
First Author: Alayna E Ernster
Poster
2022 ASCO Annual Meeting
Effects of exercise during adjuvant chemotherapy for breast cancer on long-term cardiotoxicity.
First Author: Willeke Naaktgeboren
Poster
2021 ASCO Annual Meeting
Perceived physical fatigability improves after an exercise intervention among breast cancer survivors: A pilot randomized clinical trial.
First Author: Yujia (Susanna) Qiao
Poster
2018 ASCO Annual Meeting
Symptom burden and employment status in breast cancer (BC) survivors.
First Author: Ines Maria Vaz Duarte Luis